Markets

2 Big Reasons Why Shares of Exelixis, Inc. Soared 15% in April

Nonetheless, things are looking up in more ways than one. The next big data set should be released next year when we get a look under the hood at the data from the CELESTIAL trial for hepatocellular carcinoma, or HCC. The primary endpoint for CELESTIAL is based on a statistically significant improvement in overall survival, which for cabozantinib has offered a mixed picture (hitting the mark in RCC, but missing badly in the COMET trials for metastatic castration-resistant prostate cancer).

As a shareholder of Exelixis, I remain optimistic about its future, but do understand that challenges remain. I'd encourage investors who are looking for a burgeoning cancer-focused company to give Exelixis a deeper dive.

This iSecret stock could make this pop look tiny

The world's biggest tech company forgot to show you something, but a few Wall Street analysts and the Fool didn't miss a beat: There's a small company that's powering their brand-new gadgets and the coming revolution in technology. And we think its stock price has nearly unlimited room to run for early in-the-know investors! To be one of them, just click here .

The article 2 Big Reasons Why Shares of Exelixis, Inc. Soared 15% in April originally appeared on Fool.com.

Sean Williams owns shares of Exelixis, but has no material interest in any other companies mentioned in this article. You can follow him on CAPS under the screen nameTMFUltraLong, track every pick he makes under the screen nameTrackUltraLong, and check him out on Twitter, where he goes by the handle@TMFUltraLong.The Motley Fool recommends Exelixis. Try any of our Foolish newsletter services free for 30 days . We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy .

Copyright © 1995 - 2016 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

EXEL RHHBY BMY

Other Topics

Stocks

Latest Markets Videos

The Motley Fool

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

Learn More